ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,124,549,707
- Total 13F shares
- 124,100,473
- Share change
- +44,484,180
- Total reported value
- $327,790,828
- Put/Call ratio
- 126%
- Price per share
- $2.64
- Number of holders
- 236
- Value change
- +$117,120,227
- Number of buys
- 162
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45256X103:
Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
20,344,554
|
$61,237,108 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
13,290,056
|
$40,003,068 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.67%
|
7,583,901
|
$22,827,542 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
4,289,420
|
$12,913,777 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.31%
|
3,445,097
|
$10,369,742 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
2,714,662
|
$8,171,132 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
2,333,333
|
$7,023,332 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
1,895,134
|
$5,704,353 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
1,438,416
|
$4,329,632 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
1,358,142
|
$4,088,008 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.12%
|
1,346,036
|
$4,051,568 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
1,302,083
|
$3,919,270 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
1,056,899
|
$3,181,266 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
1,018,954
|
$3,067,051 | — | 31 Mar 2025 | |
| Clearwater Capital Advisors, LLC |
13F
|
Company |
0.08%
|
846,419
|
$2,547,722 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.07%
|
827,039
|
$2,489,387 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
773,471
|
$2,328,148 | — | 31 Mar 2025 | |
| ALLEN HOLDING INC /NY |
13F
|
Company |
0.06%
|
687,571
|
$2,069,589 | — | 31 Mar 2025 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.06%
|
633,475
|
$1,906,760 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
539,643
|
$1,624,325 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
502,269
|
$1,511,830 | — | 31 Mar 2025 | |
| Accurate Wealth Management, LLC |
13F
|
Company |
0.05%
|
560,000
|
$1,472,800 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
478,323
|
$1,439,752 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.04%
|
432,341
|
$1,301,346 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
429,753
|
$1,293,557 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
410,400
|
$1,235,304 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
365,035
|
$1,098,755 | — | 31 Mar 2025 | |
| John C. Thomas |
3/4/5
|
Former Director |
—
class O/S missing
|
216,363
|
$1,086,143 | — | 31 Dec 2021 | |
| Nuveen, LLC |
13F
|
Company |
0.03%
|
359,669
|
$1,082,604 | — | 31 Mar 2025 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.03%
|
345,944
|
$1,041,292 | — | 31 Mar 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.03%
|
324,549
|
$976,892 | — | 31 Mar 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.03%
|
295,950
|
$889,330 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
237,761
|
$715,000 | — | 31 Mar 2025 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0.02%
|
236,200
|
$710,962 | — | 31 Mar 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
233,500
|
$702,835 | — | 31 Mar 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.02%
|
227,668
|
$685,281 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
219,360
|
$660,259 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
214,030
|
$644,230 | — | 31 Mar 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
205,092
|
$635,000 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
195,146
|
$587,389 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
183,763
|
$553,125 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
166,750
|
$501,916 | — | 31 Mar 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.01%
|
153,000
|
$480,420 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
152,525
|
$459,097 | — | 31 Mar 2025 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
146,458
|
$440,839 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.01%
|
137,913
|
$415,118 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
131,959
|
$397,197 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
130,668
|
$393,311 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
129,363
|
$389,383 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.01%
|
124,885
|
$375,904 | — | 31 Mar 2025 |
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2025
As of 30 Jun 2025,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,100,473 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, and AlphaCore Capital LLC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
205
Q2 2025 holders
236
Holder diff
31
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.